Category: Static

Why 40% of hospitals are still losing money, according to CFOs

As hospital margins gradually improve across the industry, a significant divide remains between higher- and lower-performing hospitals, with nearly 40% of facilities still operating in the red, according to Kaufman Hall. Multiple factors are contributi…

Ballad Health names chief revenue officer

Johnson City, Tenn.-based Ballad Health has named Shana Tate chief revenue officer, according to a Sept. 17 post on her LinkedIn page. 

UHS sells 80-bed hospital to Texas system

San Angelo, Texas-based Shannon Medical Center has acquired River Crest Hospital from King of Prussia, Pa.-based Universal Health Services, a spokesperson for UHS confirmed to Becker’s.

Radiology group urges CMS to reconsider cuts

In a Sept. 9 letter to CMS, El Segundo, Calif.-based Radiology Partners expressed concerns over the proposed 2025 Physician Fee Schedule, colorectal cancer screenings and radiation dose management. 

Radiology group urges CMS to reconsider cuts

In a Sept. 9 letter to CMS, El Segundo, Calif.-based Radiology Partners expressed concerns over the proposed 2025 Physician Fee Schedule, colorectal cancer screenings and radiation dose management. 

Nevada hospital taps CEO

Jordan Herget has been named CEO of Sierra Medical Center in Reno, Nev.

Nevada hospital taps CEO

Jordan Herget has been named CEO of Sierra Medical Center in Reno, Nev.

Mass General Brigham, Tampa General strengthen affiliation

Tampa (Fla.) General Hospital and Boston-based Mass General Brigham are strengthening their affiliation to expand access to specialty care for Florida residents. 

Mass General Brigham, Tampa General strengthen affiliation

Tampa (Fla.) General Hospital and Boston-based Mass General Brigham are strengthening their affiliation to expand access to specialty care for Florida residents. 

Sanders: Ozempic generic could cost 90% less than brand-name

Generic drug manufacturers can sell semaglutide, the generic of Ozempic, for less than $100 for a month’s supply, Sen. Bernie Sanders said Sept. 17. Before insurance, the brand-name drug costs $969 per month in the U.S.